Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 458 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. Re-verified, no change to tracked fields
  4. Re-verified, no change to tracked fields
  5. Re-verified, no change to tracked fields
Show 45 earlier versionsHide 45 earlier versions
  1. Minor Eligibility criteria expanded, about 1 word
  2. 11 versions Re-verified since Jul 30, 2026, no change to tracked fieldsv442-v452
  3. Minor Study sites: 7 to 8v441
  4. Study Status, Eligibilityv440
  5. 25 versions Re-verified since Aug 8, 2025, no change to tracked fieldsv415-v439
  6. Study Status, Study Descriptionv414
  7. 5 versions Re-verified since Jun 7, 2025, no change to tracked fieldsv409-v413
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will determine the biochemical and genetic causes of inherited immune diseases affecting lymphocyte homeostasis. Lymphocytes are a type of white blood cell that fights infections. Normally, the body keeps a precise balance in which lymphocyte growth is matched by lymphocyte death. People with constantly enlarged lymph nodes or spleen, along with autoimmune disease, immunodeficiency, lymphoma, or other immune problems affecting lymphocytes may have an abnormality of the immune system in the cell growth and cell death processes that regulate lymphocyte homeostasis. Patients who have, or are suspected of having, an inherited lymphocyte homeostasis or programmed cell death susceptibility syndrome may be eligible for this study. Relatives of patients are also included. Participants' (patients and relatives) medical records are reviewed and blood samples are drawn for studies to identify genes involved in immune disorders. Tissues that have been removed from patients for medical reasons, such as biopsied tissues, may be examined for tissue and DNA studies. Relatives are studied to determine if some of them may have a very mild form of lymphocyte homeostasis disorder. Patients who have an immune problem that the researchers wish to study further will be invited to donate additional blood samples at irregular intervals (at least once a year) and to provide an update of their medical records at the same time.
Trial Details
NCT Number NCT00246857
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
(from sponsor)
Primary Immune Deficiency
Related terms Autoimmune Diseases, Genetic Diseases, Inborn, Primary Immunodeficiency Diseases
Enrollment 5,000 participants
Start Date
Updated on ClinicalTrials.gov